Peter Kyle Heads to Washington to Push Forward UK-U.S. Trade Negotiations
British Trade Minister Peter Kyle plans to visit Washington by the year's end to advance trade talks focusing on the pharma and steel sectors. The UK seeks to eliminate U.S. steel tariffs and respond to pharmaceutical pricing disputes. Progress requires addressing concerns from the pharmaceutical industry.
British Trade Minister Peter Kyle aims to visit Washington before the year concludes, seeking to further UK-U.S. trade negotiations focusing on the pharmaceutical and steel sectors.
Earlier in the year, Britain achieved partial tariff relief from the U.S., but elements of this agreement remain unfinalized. These include efforts to reduce steel tariffs for UK firms to zero and collaborative developments in the pharmaceutical sector.
The pharmaceutical industry has expressed criticism over Britain's drug pricing, while former U.S. President Donald Trump advocated for higher drug prices in Britain and Europe. With several pharmaceutical investments paused, Kyle emphasized the importance of pharmaceutical negotiations to benefit everyday people.
(With inputs from agencies.)
ALSO READ
Britain Entices AI Firm Anthropic Amid U.S.-UK Tug of War
Britain Deploys Rapid Sentry Air Defence to Protect Gulf Interests
Britain Bolsters Gulf Security with Rapid Sentry Deployment
Britain Secures Tariff-Free Drug Deal with U.S.
Trump's Bold Pharmaceutical Tariff Plan: Impact on Drug Pricing Deals

